BMJ Innovations: Postmortems on Diagnostic Testing Start-Ups: Reports of Commercial Success and Failures and the Case of the Zombie Life Science Company
In this publication, QURE determined a five-phase framework, which predicted the success of a diagnostic company as measured by entering the market and achieving commercialization. We analyzed 28 companies over time and found that six of them were successful. All six of these companies had clear criteria across all five phases while the companies that failed did not.
Obtain Robust Clinical Utility Data